CV SciencesCVSI +9.09% Gross Margin % is 48.89% as of Mar. 2026, which is 3% above its 10-year median of 47.31. The stock has 2 warning signs investors should review. Among 938 Drug Manufacturers companies, CV Sciences ranks better than 52.13% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
CV Sciences had a gross margin of 48.89% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
CV Sciences Gross Margin % Related Terms
CV Sciences Gross Margin % Historical Data
* Premium members only.
The historical data trend for CV Sciences's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CVSI vs INM, GELS, LVRLF: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, CV Sciences's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CV Sciences Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CV Sciences's Gross Margin % distribution charts can be found below:
* The bar in red indicates where CV Sciences's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
CV Sciences (CVSI) has a Gross Margin % of 48.89% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on CV Sciences and its competitors. This is near median its historical median of 47.31. Over the past decade, CV Sciences' Gross Margin % has ranged from 34.25 to 70.22. According to the industry distribution chart, CV Sciences ranks #449 out of 938 companies in the Drug Manufacturers industry, placing it in the top 47.9%.
Is CV Sciences' Gross Margin % too high?
CV Sciences' current Gross Margin % of 48.89% is near median its 10-year median of 47.31. Over the past 10 years, this metric has ranged from a low of 34.25 to a high of 70.22. The Drug Manufacturers industry median Gross Margin % is 48.44. CV Sciences' value of 48.89% is 0.9% above this industry median. Based on the distribution chart, CV Sciences ranks #449 out of 938 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does CV Sciences' Gross Margin % compare to INM and GELS?
According to the Drug Manufacturers industry distribution chart, CV Sciences ranks #449 out of 938 companies for Gross Margin %. This puts CV Sciences in the upper half of its industry. The industry median Gross Margin % is 48.44. CV Sciences' value of 48.89% is 0.9% above this benchmark. Historically, CV Sciences' own Gross Margin % has ranged from 34.25 to 70.22 over the past decade. While the company's 10-year median is 47.31 vs. the industry median of 48.44, CV Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.44, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CV Sciences's current Gross Margin % of 48.89% is 0.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on CV Sciences and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CV Sciences's current Gross Margin % is 48.89%, which is near median its own 10-year median of 47.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CV Sciences stock overvalued right now?
Based on GuruFocus' analysis, CV Sciences (CVSI) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.03, compared to a current price of $0.02 — trading 20% below its estimated fair value. The current Gross Margin % is 48.89%, which is near median its 10-year median of 47.31 and 0.9% above the Drug Manufacturers industry median of 48.44. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For CV Sciences (CVSI), the current Gross Margin % is 48.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CV Sciences Inc is a consumer wellness company specializing in nutraceuticals and plant-based foods products. It develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol. The company sells its products under tradenames, such as +PlusCBD, PlusCBD Pet, PlusHLTH, Cultured Foods, and Lunar Fox. The company's products are sold in a variety of market sectors, including nutraceutical, beauty care, and specialty foods. The company has one operating segment, which is the business of hemp-based CBD wellness products. Geographically, all of the company's revenue is generated from United States. The company also operates a drug development program focused on developing and commercializing CBD-based novel therapeutics.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CVSI has been successfully added to your 